10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
PFIZER INC | |||
Ticker: PFE Fiscal Year: 2019 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2019 10-K (Filed: Feb 27, 2020) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
Net income before allocation to noncontrolling interests | $ 16,302 | 11,188 | 21,355 |
Foreign currency translation adjustments, net | 654 | (799) [1] | 1,116 |
Reclassification adjustments | (288) | (22) [2] | 162 |
Other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax, total | 366 | (821) | 1,278 |
Unrealized holding gains/(losses) on derivative financial instruments, net | 476 | 220 | (10) |
Reclassification adjustments for (gains)/losses included in net income | (664) | 27 | (520) [3] |
Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total | (188) | 247 | (530) |
Unrealized holding gains/(losses) on available-for-sale securities, net | (1) | (185) | 818 |
Reclassification adjustments for (gains)/losses included in net income | 39 | 124 | (244) |
Reclassification adjustments for unrealized gains included in Retained earnings | 0 | (462) [4] | 0 |
Other comprehensive income (loss), available-for-sale securities adjustment, before tax, total | 38 | (522) | 574 |
Benefit plans: actuarial losses, net | (826) | (649) | (212) |
Reclassification adjustments related to amortization | 241 | 242 | 588 |
Reclassification adjustments related to settlements, net | 274 | 142 | 117 |
Other | 22 | 112 | (145) |
Defined benefit Plan, amounts recognized in other comprehensive income (loss), net gain (loss), before tax, total | (289) | (153) | 348 |
Benefit plans: prior service costs and other, net | (7) | (9) | (2) |
Reclassification adjustments related to amortization of prior service costs and other, net | (181) | (181) | (184) |
Reclassification adjustments related to curtailments of prior service costs and other, net | (2) | (19) | (18) |
Other | 1 | 2 | 0 |
Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax | (189) | (207) | (203) |
Other comprehensive income/(loss), before tax | (262) | (1,457) | 1,468 |
Tax provision/(benefit) on other comprehensive income/(loss) | 115 | 518 | (262) |
Other comprehensive income/(loss) before allocation to noncontrolling interests | (376) | (1,975) | 1,730 |
Comprehensive income before allocation to noncontrolling interests | 15,926 | 9,214 | 23,085 |
Less: Comprehensive income attributable to noncontrolling interests | 18 | 16 | 62 |
Comprehensive income attributable to Pfizer Inc. | 15,908 | 9,198 | 23,023 |
[1] Amounts in 2019 include a gain of approximately $1.3 billion pre-tax ($978 million after-tax) related to foreign currency translation adjustments attributable to our equity method investment in the GSK Consumer Healthcare joint venture (see Note 2C), partially offset by the strengthening of the U.S. dollar against the euro and the Australian dollar, and the results of our net investment hedging program. In 2018, Foreign currency translation adjustments, net, primarily reflects the strengthening of the U.S. | |||
[2] For the year ended December 31, 2019, the foreign currency translation adjustments are primarily reclassified into (Gain) on completion of Consumer Healthcare JV transaction in the consolidated statement of income as a result of the contribution of our Consumer Healthcare business to the Consumer Healthcare joint venture with GSK. See Note 2C. For the year ended December 31, 2017, the foreign currency translation adjustments reclassified into Other (income)/deductionsnet in the consolidated statement of in | |||
[3] Reclassified into Other (income)/deductionsnet and Cost of sales in the consolidated statements of income. For additional information on amounts reclassified into Other (income)/deductionsnet and Cost of sales, see Note 7F. | |||
[4] For additional information, see Notes to Consolidated Financial StatementsNote 1B. Basis of Presentation and Significant Accounting Policies: Adoption of New Accounting Standards in 2018 in our 2018 Financial Report. |
External Links | |
PFIZER INC (PFE) Fiscal Year 2019 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |